Hospice use and high-intensity care in men dying of prostate cancer. - Wikidata - wikimedia - TriplyDB

Hospice use and high-intensity care in men dying of prostate cancer.

Hospice use and high-intensity care in men dying of prostate cancer.

http://www.wikidata.org/entity/Q35777885

about

Measuring intensity of end of life care: a systematic review Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: a systematic review.Hospice admissions for cancer in the final days of life: independent predictors and implications for quality measures.Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer.Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients.Hospice care and resource utilization in Medicare beneficiaries with heart failure End-of-Life Medical Costs of Medicaid Cancer Patients.Comorbid diabetes and end-of-life expenditures among Medicare beneficiaries with heart failure.Rates and risks for late referral to hospice in patients with primary malignant brain tumors.Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.Factors associated with aggressive end of life cancer care.Emergency Care Use and the Medicare Hospice Benefit for Individuals with Cancer with a Poor Prognosis Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma Prostate cancer in men of African origin.Impact of Inpatient Palliative Care on Treatment Intensity for Patients with Serious Illness.Quality of end-of-life care among rural Medicare beneficiaries with colorectal cancer.A Longitudinal Analysis of Site of Death: The Effects of Continuous Enrollment in Medicare Advantage Versus Conventional Medicare.Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma.End-of-life care in patients with primary malignant brain tumors: early is better.Fatalism and educational disparities in beliefs about the curability of advanced cancer.Treatment given near the end of life in castration-resistant prostate cancer.Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.Dying From Cancer: Communication, Empathy, and the Clinical Imagination.Preference for Palliative Care in Cancer Patients: Are Men and Women Alike?

P2860

Q28080642-EEE85B09-B030-4D75-B9E5-3BDC0A94ADF2 Q30827101-8B12C44C-E830-4EBF-8972-7FE17DE18B6C Q34226035-3C072ACA-5985-4098-AA76-AA7EA215BA4B Q34372662-513A78B1-4F9F-403C-B6A5-31776270C0B8 Q35213707-45EC0449-E472-4F2F-A8AD-7AB45B95F101 Q35565875-3A8D68A5-19A1-45C1-923F-0C89647DC0B8 Q35670713-7F677F93-37BF-4826-B3D6-7CFC1C6085B6 Q35774470-CDE27AE9-2B80-41A3-A4C3-D92DF284DAD1 Q36367431-A0444337-7610-4735-946B-2ACD7E51201E Q36421813-759F4327-2D51-4E67-9C96-8953B9328988 Q36510968-A041FC4E-D2E6-412A-991E-EED7C9F0736C Q36716711-EABC6C7B-78C8-4F9F-ADAA-EA813B5FFC5B Q37228662-858D4710-5271-49F5-88AF-940A412927C9 Q38683379-1BAB0717-CC0C-4657-A580-D31CEB37AD15 Q38859875-AE8286DF-99E1-441D-971D-2382EBBBA963 Q39197230-352D59C9-F150-4167-BC6C-AF7F7946906B Q39756169-4150B0C5-2A15-47C2-BA06-F54367237CFF Q40490895-B31E332B-E0B5-4949-9070-5ABD67288D2C Q43132427-616D8F94-2C20-4C4D-8C74-FD650F75615A Q47319910-6CADA22C-3184-4838-9D3E-FECF1AED1B1F Q48503121-5F6D3491-D796-4D83-9C28-1EA3B017B9C9 Q51833841-04FEFCFA-D957-4083-B28E-550CEBA4F872 Q52570169-92FA535F-19C3-47EB-BB4B-3F5E9F8C3C58 Q52629758-8EA629EA-22AB-4DC5-82E3-66314BCC5A6F

P2860

Hospice use and high-intensity care in men dying of prostate cancer.

http://www.wikidata.org/entity/Q35777885

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Hospice use and high-intensity care in men dying of prostate cancer.

@ast

Hospice use and high-intensity care in men dying of prostate cancer.

@en

type

label

Hospice use and high-intensity care in men dying of prostate cancer.

@ast

Hospice use and high-intensity care in men dying of prostate cancer.

@en

prefLabel

Hospice use and high-intensity care in men dying of prostate cancer.

@ast

Hospice use and high-intensity care in men dying of prostate cancer.

@en

P1433

Q35777885-F64C1375-2A3E-4BED-95FF-826C7EC39B2A

P1476

Q35777885-15CE4A89-C895-43A5-9BE4-90AB6E82ED86

P2093

Q35777885-226D726F-A46B-40C2-AF29-070A8F30DA39

Q35777885-9B27DB98-7397-4A4C-BB51-B35D25A08860

Q35777885-A5E85C31-C34B-4F86-8CA5-BE30120E401A

Q35777885-DCA229AC-FFE9-48A9-8EDA-22CA0EA609A3

Q35777885-E0FFB02A-573D-47EE-A406-08DD625D250B

Q35777885-F368BE4B-4BCD-4AD6-99B2-1772843B7E90

Q35777885-FCC2C75A-54F5-4C73-A73D-77E287D49A17

P2860

Q35777885-13950DE6-6414-40AE-AB32-78EA5B01A3FF

Q35777885-2FF06228-70B9-490D-97FB-2F6DB0B629DE

Q35777885-30F94994-F001-4DB7-8A55-491ACE21F2C4

Q35777885-371F2568-1CB1-47B7-A021-D0AEB88D34E5

Q35777885-450D3135-CCFC-47A8-A9FA-2A128AC47ADF

Q35777885-470EF4EC-ABFE-4A66-ABBF-0E557363A7E3

Q35777885-47D680C6-29EB-42FE-83C2-5E5B74470D3E

Q35777885-4C7FE6CB-479C-4192-8E55-7627EC8130B0

Q35777885-534A7D1D-023E-498B-BF89-BE2FB7BD9FB1

Q35777885-596A34A1-59D4-482B-96DC-D476A17A205E

P304

Q35777885-57FC2160-B0E4-487C-9248-1E56CA9BDD78

P31

Q35777885-0F754E81-C207-4147-A15F-F06B8BD071E2

P356

Q35777885-D6EA4920-0562-4775-9E73-BDEBD5346C9E

P407

Q35777885-329EA09A-EF64-42FB-80B8-8D6D6A446A42

P433

Q35777885-EBEDDA63-3BBB-4C4A-9D2C-428F2D18C0F0

P478

Q35777885-FAF66A65-BEC4-47A7-B549-45DF4F56B768

P50

Q35777885-971BCF71-5E9E-4DE1-8375-7DC0DF32B093

P577

Q35777885-6C4219F8-AF04-42A2-825F-0B01F2595E3A

P5875

Q35777885-E65AF240-9C68-4076-B383-9574A981AF56

P698

Q35777885-5FD4D34F-55FB-4E71-9A25-150DD4EF38B2

P932

Q35777885-C5CD4E3F-EE00-4654-B8A0-DEA473E655DC

P356

ARCHINTERNMED.2010.394

P1433

JAMA Internal Medicine

P1476

Hospice use and high-intensity care in men dying of prostate cancer

@en

P2093

Christopher S Saigal

http://www.w3.org/2001/XMLSchema#string

David C Miller

http://www.w3.org/2001/XMLSchema#string

Janet Hanley

http://www.w3.org/2001/XMLSchema#string

Jonathan Bergman

http://www.w3.org/2001/XMLSchema#string

Karl A Lorenz

http://www.w3.org/2001/XMLSchema#string

Mark S Litwin

http://www.w3.org/2001/XMLSchema#string

Urologic Diseases in America Project

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Comparing the quality of death for hospice and non-hospice cancer patients.

Identifying potential indicators of the quality of end-of-life cancer care from administrative data.

Clinical practice. Palliative care.

Hospice use by Hispanic and non-Hispanic white cancer decedents.

Cost savings at the end of life. What do the data show?

A systematic review of satisfaction with care at the end of life.

Patterns and predictors of home health and hospice use by older adults with cancer.

Ethnic disparities in hospice use among Asian-American and Pacific Islander patients dying with cancer.

P304

204-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2010.394

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47395711

http://www.w3.org/2001/XMLSchema#string

P698

20937914

http://www.w3.org/2001/XMLSchema#string

P932

3286613

http://www.w3.org/2001/XMLSchema#string